# DUKE UNIVERSITY: 6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | DUKE UNIVERSITY |
| Location | DURHAM, NC |
| Project | 6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration |
| Project number | 3U19CA264385-05S1 |
| Mechanism | U19 |
| Institute | National Cancer Institute |
| Award | $823,182 |
| Awarded | 2026-09-17 |
| Project period | 2021-09-13 to 2027-08-31 |
| UEI | TP7EK8DZV6N5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11607175). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.